More than 700 people from all over Europe voted and selected their favourite entrepreneurial team: Karion Therapeutics from the University of Minho.
Karion is developing a novel drug candidate for aggressive cancers with an unprecedented mode of action. Unlike any other in the market, this drug candidate has a highly effective and safe profile, allowing to extend cancer patient survival and improve patients‘ quality of life.
Marta Costa, CEO of Karion said: “It is an honour to win the Arqus International Innovators Award, especially considering the quality of the other projects that have participated. Thank you so much Arqus Alliance!”
Each partner university had selected one team from their local program to participate in the European final in Leipzig.
The pitch videos of all seven participating teams can still be watched at https://arqus-alliance.eu/event/arqus-international-innovators-award-2023/
The winner was announced on June 27th at the Born Global Startup Festival in Leipzig where we celebrated with guests from Arqus universities and more than 200 international students, Ph.D.s/ Post Docs and alumni with already existing business ideas or somehow interested in setting up a startup in Germany.
Photo credits: Swen Reichhold
